user

Eversense Continuous Glucose Monitoring System

被引：0
|
作者：
Crowner, Jamila [1 ]
Gabenski, Brandon [1 ]
Okere, Arinzechukwu N. [2 ]
Honeywell, Marlon S. [1 ]
机构：
[1] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA
[2] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Pharm, Tallahassee, FL 32307 USA
来源：
US PHARMACIST | 2020年 / 45卷 / 09期
关键词：
PROSPECTIVE MULTICENTER EVALUATION; ACCURACY; SENSOR;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：30 / 32
页数：3
相关论文
共 50 条
  • [1] Safety of Microdose Dexamethasone Acetate in the Eversense Long-Term Implantable Continuous Glucose Monitoring System
    Kelley, E. L.
    Haridas, Haritha
    Lorenz, Carrie
    [J]. DIABETES, 2018, 67
  • [2] FEAR NO HYPO - FEASIBILITY EVALUATION OF THE IMPACT ON GLUCOSE CONTROL AND SAFETY OF THE EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE I DIABETIC YOUTH
    Biester, T.
    Nieswandt, A.
    Biester, S.
    Stephan, C.
    Remus, K.
    Adolph, K.
    Kottmann, T.
    Kordonouri, O.
    Danne, T.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A95 - A95
  • [3] Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
    Deiss, Dorothee
    Szadkowska, Agnieszka
    Gordon, Debbie
    Mallipedhi, Akhila
    Schuetz-Fuhrmann, Ingrid
    Aguilera, Eva
    Ringsell, Corina
    De Block, Christophe
    Irace, Concetta
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (05) : 254 - 264
  • [4] Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System
    Lorenz, Carrie
    Sandoval, Wendolyn
    Mortellaro, Mark
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (05) : 344 - 352
  • [5] The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy
    Oppel, Eva
    Kamann, Stefanie
    Heinemann, Lutz
    Reichl, Franz-Xaver
    Hoegg, Christof
    [J]. CONTACT DERMATITIS, 2020, 82 (02) : 101 - 104
  • [6] Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy
    Irace, Concetta
    Cutruzzola, Antonio
    Tweden, Katherine
    Kaufman, Francine R.
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (10) : 909 - 914
  • [7] Calibration of the continuous glucose monitoring system for transient glucose monitoring
    Lesperance, Leann M.
    Spektor, Anna
    McLeod, Kenneth J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2007, 9 (02) : 183 - 190
  • [8] Microdialysis system for continuous glucose monitoring
    Steinkuhl, R
    Sundermeier, C
    Hinkers, H
    Dumschat, C
    Cammann, K
    Knoll, M
    [J]. SENSORS AND ACTUATORS B-CHEMICAL, 1996, 33 (1-3) : 19 - 24
  • [9] MiniMed continuous glucose monitoring system
    不详
    [J]. BIOSENSORS & BIOELECTRONICS, 2000, 14 (10-11): : AR1 - AR1
  • [10] ASSESSMENT AND COMPARISON OF THE MEASUREMENT ERROR COMPONENTS OF DEXCOM G5 MOBILE AND EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEMS
    Vettoretti, M.
    Boscari, F.
    Bruttomesso, D.
    Facchinetti, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A46 - A46
12345